Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03538574 · ClinicalTrials.gov registry record · NA
Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT03538574 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 139 participants.
The verdict
NCT03538574, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
Treatment of insomnia in caregivers is needed given that 60% of Alzheimer disease caregivers report sleep complaints, and insomnia may add to the burden of AD caregiving and contribute to morbidity and mortality risk. This is the first intervention trial in AD caregivers to target insomnia and also evaluate two mechanisms of chronic disease risk, inflammation and cellular aging
Interventions
- BEHAVIORAL CBT-I
- BEHAVIORAL MAP-I
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03538574
The ClinicalTrials.gov registry entry for NCT03538574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CBT-I is the first listed.
NCT03538574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03538574 about?
NCT03538574 is a clinical study titled "Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers". Treatment of insomnia in caregivers is needed given that 60% of Alzheimer disease caregivers report sleep complaints, and insomnia may add to the burden of AD caregiving and contribute to morbidity and mortality risk. This is the first intervention trial in AD caregivers to target insomnia and also ...
What is the current status of trial NCT03538574?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2018-07-01. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT03538574?
The interventions under investigation include: CBT-I (BEHAVIORAL), MAP-I (BEHAVIORAL).
Who is sponsoring clinical trial NCT03538574?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.